Skip to main content
. 2012 Feb 8;67(5):1217–1223. doi: 10.1093/jac/dkr596

Figure 1.

Figure 1.

Mean (±SEM) plasma concentration versus time of (a) artemether, (b) dihydroartemisinin and (c) lumefantrine for participants taking artemether/lumefantrine alone (AL alone) and artemether/lumefantrine in combination with lopinavir/ritonavir (AL plus LPV/r).